PDGFRA and hepatocellular carcinoma: Platelet-derived growth factor receptor alpha (PDGFRα), stem cell factor receptor (KIT) and rearranged during transfection (RET), are more effective for the treatment of patients with unresectable HCC (Faivre et al., 2020).